mesalamine has been researched along with Keratoconjunctivitis in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilyard, KG | 1 |
| Joseph, EC | 2 |
| Metcalf, R | 1 |
| Barnett, KC | 2 |
3 other studies available for mesalamine and Keratoconjunctivitis
| Article | Year |
|---|---|
Mesalazine: an overview of key preclinical studies.
Topics: Administration, Oral; Aminosalicylic Acids; Animals; Dogs; Dose-Response Relationship, Drug; Drug Ev | 1990 |
Keratoconjunctivitis sicca and the treatment of canine colitis.
Topics: Aminosalicylic Acids; Animals; Colitis; Dog Diseases; Dogs; Female; Keratoconjunctivitis; Keratoconj | 1986 |
Keratoconjunctivitis sicca in the dog following 5-aminosalicylic acid administration.
Topics: Aminosalicylic Acids; Animals; Dogs; Female; Keratoconjunctivitis; Keratoconjunctivitis Sicca; Male; | 1987 |